Buc, France

Louis-Marie Houdebine

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: National Institute for Agricultural Research, Aventis Pharmaceuticals Inc.. Active years: 1999-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis-Marie Houdebine. Retrieved from https://idiyas.com/inventor/louis-marie-houdebine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0


Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 59(Granted Patents)


Company Filing History:


Years Active: 1999-2009

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Louis-Marie Houdebine: Innovator in Transgenic Animal Research

Introduction

Louis-Marie Houdebine is a prominent inventor known for his contributions to the field of transgenic animal research. He is based in Buc, France, and holds a total of four patents. His work primarily focuses on the expression of transgenes in milk from transgenic animals, which has significant implications for biotechnology and medicine.

Latest Patents

One of Houdebine's latest patents is titled "Position-independent and tissue specific expression of a transgene in milk of transgenic animals." This invention relates to an isolated insulator DNA molecule that consists of the 5' and 3' regions of the porcine wrap gene locus. It provides a method for insulating the expression of an introduced heterologous gene from silencing and variegation effects in chromatin. The invention also encompasses mammalian cells that include this insulator DNA molecule and non-human animals capable of expressing a polypeptide of interest in milk.

Another significant patent is for a "Transgenic rabbit that expresses a functional human lipoprotein (a)." This patent describes a transgenic rabbit that contains genomic DNA sequences encoding apolipoprotein (a) and apolipoprotein B polypeptides. These components are capable of combining to produce lipoprotein (a). The patent also outlines a process for creating such a rabbit and its use in identifying compounds effective in treating human diseases associated with Lp(a) expression.

Career Highlights

Houdebine has worked with notable organizations, including the National Institute for Agronomic Research (Institut National De La Recherche Agronomique) and Aventis Pharmaceuticals Inc. His career has been marked by a commitment to advancing the understanding of genetic engineering in animals, particularly in the context of human health.

Collaborations

Throughout his career, Houdebine has collaborated with several professionals in his field, including Celine Viglietta and Eve Devinoy. These collaborations have contributed to the development of innovative solutions in transgenic research.

Conclusion

Louis-Marie Houdebine's work in transgenic animal research has led to significant advancements in biotechnology. His patents reflect a deep understanding of genetic engineering and its potential applications in medicine. His contributions continue to influence the field and pave the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…